Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview of lecture: introduction
- Challenges of immune recognition
- Antigen recognition has unique features
- Overview of lecture: key binding concepts
- Affinity
- Kinetics
- Factors affecting affinity
- Affinity & kinetic constants for key immune interactions
- Avidity
- Multivalent high-avidity molecules
- Overview of lecture: measuring binding properties
- Methods for measuring binding properties
- Principles of surface plasmon resonance
- Measuring the affinity constant (1)
- Measuring the affinity constant (2)
- Scatchard plot
- Measuring affinity by SPR: an example
- Measuring the dissociation rate constant
- Measuring the association rate constant
- Example of measuring binding kinetics
- Measuring avidity
- Overview of lecture: cell surface molecules
- Cell surface molecule interactions are distinct
- Consequence of constraint to membranes
- Consequence of mechanical forces
- Consequence of cooperativity
- Cooperative binding example
- CD2/CD48 complex size affects TCR binding
- Conclusions
- Acknowledgments
Topics Covered
- Challenges of immune recognition
- Key binding concepts
- Affinity
- Kinetics
- Avidity
- Measuring binding properties
- Cell surface molecules
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
van der Merwe, A. (2020, November 30). Affinity, avidity and kinetics in immune recognition [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/YFIE6191.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Anton van der Merwe has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Anton Van der Merwe from the University of Oxford,
and I'm going to be talking about affinity,
avidity, and kinetics in immune recognition.
0:11
Here's an overview of my lecture.
After this introduction, I'll be talking about the key binding concepts,
discussing measuring binding properties,
and then finish by discussing the special features of cell surface molecules.
0:25
Now immune recognition is driven by protein-ligand interactions,
and the proteins and ligands can either be soluble or surface-associated.
A particular challenge for immune recognition is that the ligands e.g,
the antigens often arise from infectious organisms or cancer cells.
They are very diverse and can evolve rapidly.
To meet this challenge, the recognition proteins also
need to be very diverse and to be able to evolve rapidly.
Now the binding properties such as the affinity and kinetics of
immune protein-ligand interactions or what determines the functional outcome of binding.
Understanding these properties and how they measured
is important for understanding immune responses.
1:04
Antigen recognition involves hugely diverse, somatically generated,
and clonally expressed T and B cell antigen receptors,
also called TCR receptors and antibodies.
These develop on T and B cells during their development,
and this development includes
positive and negative selection events that depend
on the affinity of these receptors for self-antigen.
Now each TCR receptor on a maturity cell combine multiple similar ligands and
needs to able to discriminate between them based
on subtle differences in affinity and kinetics.
TCRs receptors and primary antibodies actually have quite low affinity for the ligand.
This isn't a problem for TCR receptors because TCR receptors and their ligands are
on cells and recognition that a cell-cell interface can tolerate low affinities.
It is a problem however for antibodies.
Primary antibodies compensate for the low-affinity
by increasing the valency of binding or the avidity,
and antibodies can undergo affinity maturation to
become high-affinity secondary antibodies.